Developer docs
API playgroundTry for free, no card

Search company profiles

Pressure BioSciences

Full company profile

uuid0006vfl

Namestring
Pressure BioSciences
Legal namestring
Pressure BioSciences, Inc.
Company typeenum
Public
Founded yearint
1978
Descriptiontext

Pressure BioSciences, Inc. (OTCQB: PBIO) is a publicly traded life sciences instrumentation company headquartered at 480 Neponset St., Canton, Massachusetts. The business traces its origins to Boston Biomedica, founded in 1978 by Richard T. Schumacher, and was restructured under the Pressure BioSciences name in 2004. The company develops and commercializes three patented, pressure-based technology platforms: Pressure Cycling Technology (PCT) for biological sample preparation, the BaroFold (PreEMT) platform for high-pressure protein refolding of therapeutic proteins, and Ultra Shear Technology (UST) for nanoemulsion manufacturing of oil-in-water formulations. Its flagship instrument, the Barocycler 2320EXT, is a benchtop system that processes up to 16 samples simultaneously using PCT MicroTubes. The company reports more than 300 PCT systems installed in approximately 200 academic, government, pharmaceutical, and biotech research sites worldwide, supported by an IP estate of 24+ issued US patents and 32+ pending applications and a 488+ document publications library with 120+ peer-reviewed citations of the PCT platform.

The company generates revenue through four primary streams: instrument sales (Barocycler 2320EXT, BaroShear K45), contract research services using BaroFold protein-refolding technology, licensing of platform IP, and, since the January 2024 acquisition of Uncle Bud's, direct-to-consumer sales of natural wellness products (CBD skincare, beverages, pet care) via the Uncle Bud's brand and e-commerce storefront. Distribution is hybrid: direct enterprise sales and contract services are supplemented by an exclusive distributor network covering Japan (Veritas), China (PRS International Trade), Europe (bioanalytic), South Korea (SCINCO), and Austria (Oroboros). Pricing is quote-based and not publicly disclosed.

In January 2024, Pressure BioSciences acquired Uncle Bud's Health & Wellness, signaling a strategic pivot toward faster-moving consumer categories while continuing to serve its installed base of life sciences customers. The company is led by founder and CEO Richard T. Schumacher, with Dr. Alexander Lazarev as Chief Science Officer, Jeffrey N. Peterson as Chairman, and Edmund Ting as Senior VP of Engineering. Financial scale remains small: one disclosed revenue reference is approximately $1.98 million against a cumulative net loss footprint of $29.31 million, with headcount of 11-50.

Short descriptiontext

Pressure BioSciences (OTCQB: PBIO) develops patented pressure-based instrumentation for life sciences, including the PCT, BaroFold, and UST platforms. It serves pharma, biotech, academic, and government laboratories, and since 2024 also sells consumer wellness products through its Uncle Bud's subsidiary.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersCanton, United States
HQ citystring
Canton
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
pressure cycling technology, laboratory sample preparation, protein refolding instruments, nanoemulsion processing equipment, biotherapeutic manufacturing tools
Industry5 codes
1Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
CodeHLAGAIAJPrimaryYes
2General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens)
CodeHLAGAIACPrimaryNo
3Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media)
CodeHLAAAJAAPrimaryNo
4Analytical Development & QC Testing (Release/Stability/Potency)
CodeHLAGAGAFPrimaryNo
5Raw Materials & Critical Reagents Supply Services (media, resins, single-use)
CodeHLAAAKAIPrimaryNo
NAICS code3 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code3 codes
  • Laboratory Analytical Instruments3826
  • Services-Commercial Physical & Biological Research8731
  • Laboratory Apparatus & Furniture3821
Product category
Laboratory Instrumentation
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Instrument Sales
TypeHardware Sales
Description

Sale of pressure-based instruments including Barocycler 2320EXT and BaroShear K45 for research and commercial applications in life sciences.

pressurebiosciences.com
2Contract Services
TypeProfessional Services
Description

BaroFold technology offered through contract services for protein refolding and therapeutic protein development for industry partners.

pressurebiosciences.com
3Consumer Health Products
TypeHardware Sales
Description

Revenue from Uncle Bud's health and wellness brand including CBD-based skincare, beverages, and pet care products.

ir.pressurebiosciences.com
4Licensing
TypeLicensing Royalties
Description

Research and manufacturing licenses available for BaroFold and other technology platforms.

pressurebiosciences.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels8 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 5 records shown
1BaroShear K45
Description

Instrument for efficient preparation of high quality, water-soluble nanoemulsions of CBD oil

pressurebiosciences.com
+4 more records
Core offering1 text field

Pressure BioSciences develops, manufactures, and sells proprietary pressure-based laboratory instrumentation, including the Barocycler 2320EXT and BaroShear K45 systems, alongside consumables and contract research services. The instruments support biological sample preparation, high-pressure protein refolding (BaroFold), and nanoemulsion manufacturing (Ultra Shear Technology) for the worldwide life sciences industry. The company also markets consumer health and wellness products through its acquired Uncle Bud's subsidiary.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 300+ PCT instrument systems placed in 200+ research sites worldwide
+2 more records
Product overview1 text field

Pressure BioSciences is a life sciences instrumentation company offering three patented pressure-based platform technologies: the PCT (Pressure Cycling Technology) Platform for biological sample preparation, the BaroFold Platform for high-pressure protein refolding, and the UST (Ultra Shear Technology) Platform for nanoemulsion manufacturing. The core product is the Barocycler 2320EXT instrument, supplemented by the Baroshear K45 for CBD nanoemulsion preparation. Through its subsidiary Uncle Bud's, the company also offers consumer wellness products. Services include contract research using BaroFold technology. The company serves academic, government, pharmaceutical, and biotech research laboratories worldwide.

Scale indicator7 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-11
Description

Acquisition of Uncle Bud's, a natural wellness brand, to integrate UltraShear technology into consumer health products. Transaction involves exchange of preferred stock convertible into common shares with performance-based earnouts. Combined entity aims to expand into skincare, beverages, and pet care markets. Transaction expected to close by January 19, 2024.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2024-01-01
Description

Partnership with Vita-Forte, the largest global supplier of freeze-dried Acai, to commercialize highly potent, multi-antioxidant UltraShear (UST) nanoemulsion oral spray product.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive distributor agent for Japan handling distribution of Pressure BioSciences products in the Japanese market.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive distributor agent for China handling distribution of Pressure BioSciences products in the Chinese market.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive distributor agent for Europe handling distribution of Pressure BioSciences products across European markets.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Exclusive distributor agent for South Korea handling distribution of Pressure BioSciences products in the Korean market.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Distributes SHREDDER SG3 and Shredder Tubes only in Austria, representing a limited distribution arrangement for specific products.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat3 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Pressure BioSciences

Laboratory Instrumentationpressurebiosciences.com

Pressure BioSciences (OTCQB: PBIO) develops patented pressure-based instrumentation for life sciences, including the PCT, BaroFold, and UST platforms. It serves pharma, biotech, academic, and government laboratories, and since 2024 also sells consumer wellness products through its Uncle Bud's subsidiary.

What Pressure BioSciences does

Pressure BioSciences, Inc. (OTCQB: PBIO) is a publicly traded life sciences instrumentation company headquartered at 480 Neponset St., Canton, Massachusetts. The business traces its origins to Boston Biomedica, founded in 1978 by Richard T. Schumacher, and was restructured under the Pressure BioSciences name in 2004. The company develops and commercializes three patented, pressure-based technology platforms: Pressure Cycling Technology (PCT) for biological sample preparation, the BaroFold (PreEMT) platform for high-pressure protein refolding of therapeutic proteins, and Ultra Shear Technology (UST) for nanoemulsion manufacturing of oil-in-water formulations. Its flagship instrument, the Barocycler 2320EXT, is a benchtop system that processes up to 16 samples simultaneously using PCT MicroTubes. The company reports more than 300 PCT systems installed in approximately 200 academic, government, pharmaceutical, and biotech research sites worldwide, supported by an IP estate of 24+ issued US patents and 32+ pending applications and a 488+ document publications library with 120+ peer-reviewed citations of the PCT platform.

The company generates revenue through four primary streams: instrument sales (Barocycler 2320EXT, BaroShear K45), contract research services using BaroFold protein-refolding technology, licensing of platform IP, and, since the January 2024 acquisition of Uncle Bud's, direct-to-consumer sales of natural wellness products (CBD skincare, beverages, pet care) via the Uncle Bud's brand and e-commerce storefront. Distribution is hybrid: direct enterprise sales and contract services are supplemented by an exclusive distributor network covering Japan (Veritas), China (PRS International Trade), Europe (bioanalytic), South Korea (SCINCO), and Austria (Oroboros). Pricing is quote-based and not publicly disclosed.

In January 2024, Pressure BioSciences acquired Uncle Bud's Health & Wellness, signaling a strategic pivot toward faster-moving consumer categories while continuing to serve its installed base of life sciences customers. The company is led by founder and CEO Richard T. Schumacher, with Dr. Alexander Lazarev as Chief Science Officer, Jeffrey N. Peterson as Chairman, and Edmund Ting as Senior VP of Engineering. Financial scale remains small: one disclosed revenue reference is approximately $1.98 million against a cumulative net loss footprint of $29.31 million, with headcount of 11-50.

Pressure BioSciences firmographics

Firmographics
Name
Pressure BioSciences
Legal name
Pressure BioSciences, Inc.
Website
https://pressurebiosciences.com
Company type
Public
Founded year
1978
Operating status
Operating
Headcount range
11–50 employees
Short description
Pressure BioSciences (OTCQB: PBIO) develops patented pressure-based instrumentation for life sciences, including the PCT, BaroFold, and UST platforms. It serves pharma, biotech, academic, and government laboratories, and since 2024 also sells consumer wellness products through its Uncle Bud's subsidiary.
Ownership category
akta.pro rank

Pressure BioSciences industry classification

Industry
Product category
Laboratory Instrumentation
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731), Laboratory Apparatus & Furniture (3821)
akta.pro primary industry
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats) (HLAGAIAJ)
akta.pro secondary industries
General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens) (HLAGAIAC), Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media) (HLAAAJAA), Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF), Raw Materials & Critical Reagents Supply Services (media, resins, single-use) (HLAAAKAI)

Keywords

  • Pressure cycling technology
  • Laboratory sample preparation
  • Protein refolding instruments
  • Nanoemulsion processing equipment
  • Biotherapeutic manufacturing tools

Where Pressure BioSciences is headquartered

Location

Headquarters

HQ city
Canton
HQ country
United States
HQ region
North America

Offices2 records

Markets served

Pressure BioSciences business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing

Revenue model

  1. Instrument Sales: Sale of pressure-based instruments including Barocycler 2320EXT and BaroShear K45 for research and commercial applications in life sciences.
  2. Contract Services: BaroFold technology offered through contract services for protein refolding and therapeutic protein development for industry partners.
  3. Consumer Health Products: Revenue from Uncle Bud's health and wellness brand including CBD-based skincare, beverages, and pet care products.
  4. Licensing: Research and manufacturing licenses available for BaroFold and other technology platforms.

Go-to-market motion2 records

Distribution channels8 records

Marketing channels6 records

Pressure BioSciences product offering

Product offering

Core offering

Pressure BioSciences develops, manufactures, and sells proprietary pressure-based laboratory instrumentation, including the Barocycler 2320EXT and BaroShear K45 systems, alongside consumables and contract research services. The instruments support biological sample preparation, high-pressure protein refolding (BaroFold), and nanoemulsion manufacturing (Ultra Shear Technology) for the worldwide life sciences industry. The company also markets consumer health and wellness products through its acquired Uncle Bud's subsidiary.

Product overview

Pressure BioSciences is a life sciences instrumentation company offering three patented pressure-based platform technologies: the PCT (Pressure Cycling Technology) Platform for biological sample preparation, the BaroFold Platform for high-pressure protein refolding, and the UST (Ultra Shear Technology) Platform for nanoemulsion manufacturing. The core product is the Barocycler 2320EXT instrument, supplemented by the Baroshear K45 for CBD nanoemulsion preparation. Through its subsidiary Uncle Bud's, the company also offers consumer wellness products. Services include contract research using BaroFold technology. The company serves academic, government, pharmaceutical, and biotech research laboratories worldwide.

Differentiator

Problem solved

Functional benefit

Brands

  • BaroShear K45: Instrument for efficient preparation of high quality, water-soluble nanoemulsions of CBD oil
  • BaroFold
  • PreEMT
  • Barocycler 2320EXT
  • Uncle Bud's

Quantifiable outcome

  • 300+ PCT instrument systems placed in 200+ research sites worldwide
  • +2 more outcomes

Companies that use Pressure BioSciences

Customer profile

Named customers4 records

Segments5 records

Pressure BioSciences technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Pressure BioSciences partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and minor.

  • Uncle Bud'scoreStrategic or Co-development Partner · 11 January 2024Acquisition of Uncle Bud's, a natural wellness brand, to integrate UltraShear technology into consumer health products. Transaction involves exchange of preferred stock convertible into common shares with performance-based earnouts. Combined entity aims to expand into skincare, beverages, and pet care markets. Transaction expected to close by January 19, 2024.
  • Vita-FortecoreStrategic or Co-development Partner · 1 January 2024Partnership with Vita-Forte, the largest global supplier of freeze-dried Acai, to commercialize highly potent, multi-antioxidant UltraShear (UST) nanoemulsion oral spray product.
  • Veritas, Inc.coreChannel Partner/ Reseller/ DistributorExclusive distributor agent for Japan handling distribution of Pressure BioSciences products in the Japanese market.
  • PRS International Trade (Shanghai) Co.,LtdcoreChannel Partner/ Reseller/ DistributorExclusive distributor agent for China handling distribution of Pressure BioSciences products in the Chinese market.
  • bioanalyticcoreChannel Partner/ Reseller/ DistributorExclusive distributor agent for Europe handling distribution of Pressure BioSciences products across European markets.
  • SCINCOcoreChannel Partner/ Reseller/ DistributorExclusive distributor agent for South Korea handling distribution of Pressure BioSciences products in the Korean market.
  • OroborosminorChannel Partner/ Reseller/ DistributorDistributes SHREDDER SG3 and Shredder Tubes only in Austria, representing a limited distribution arrangement for specific products.

Scale indicators7 records

Recent moves5 records

Expansion highlights5 records

Pressure BioSciences competitors and assessment

Company assessment

Market position

Competitive moat3 records

Key highlights7 records

Customer concentration

Pressure BioSciences social profiles

Digital presence

Pressure BioSciences financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Pressure BioSciences leadership team

Management profile

Number of profiles

Pressure BioSciences subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Pressure BioSciences funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Pressure BioSciences M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Pressure BioSciences

What does Pressure BioSciences do?

Pressure BioSciences develops, manufactures, and sells proprietary pressure-based laboratory instrumentation, including the Barocycler 2320EXT and BaroShear K45 systems, alongside consumables and contract research services. The instruments support biological sample preparation, high-pressure protein refolding (BaroFold), and nanoemulsion manufacturing (Ultra Shear Technology) for the worldwide life sciences industry. The company also markets consumer health and wellness products through its acquired Uncle Bud's subsidiary.

Is Pressure BioSciences a public or private company?

Pressure BioSciences is a public company. It is currently operating.

When was Pressure BioSciences founded?

Pressure BioSciences was founded in 1978. It employs 11 to 50 people.

Where is Pressure BioSciences based?

Pressure BioSciences is headquartered in Canton, United States, in the North America region.

How does Pressure BioSciences make money?

Four revenue lines are on record. Instrument Sales are the primary driver. The others are contract Services, consumer Health Products and licensing.

Does Pressure BioSciences have an API?

No public API is recorded for Pressure BioSciences.

What industry is Pressure BioSciences in?

Pressure BioSciences's product category is Laboratory Instrumentation. Its primary akta.pro industry code is HLAGAIAJ, Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats), with a secondary code of HLAGAIAC, General Lab Equipment (Centrifuges, Incubators, Shakers, Ovens). Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Defense WorldHead to Head Review: Lucid Diagnostics (NASDAQ:LUCD) vs. Pressure BioSciences (OTCMKTS:PBIO)This article provides a head-to-head comparison of two small-cap medical companies, Lucid Diagnostics and Pressure BioSciences, evaluating them across 12 financial and market metrics including volatility, profitability, valuation, analyst recommendations, and institutional ownership.Defense WorldHead-To-Head Analysis: Disaboom (OTCMKTS:MEDH) vs. Pressure BioSciences (OTCMKTS:PBIO)A head-to-head financial comparison between Disaboom (Dazed, Inc.) and Pressure BioSciences was published, analyzing risk, profitability, ownership, and valuation metrics for both OTC-traded stocks. Disaboom reported revenue of $1.76 million with net income of $270,000 and EPS of $0.01, while Pressure BioSciences reported higher revenue of $1.98 million but a net loss of $29.31 million and EPS of -$0.96. The analysis concludes that Disaboom outperforms Pressure BioSciences on 6 of 9 factors compared, though Pressure BioSciences trades at a lower price-to-earnings ratio.Defense WorldHead-To-Head Comparison: Pressure BioSciences (OTCMKTS:PBIO) and Artivion (NYSE:AORT)This article provides a head-to-head financial comparison between small-cap medical companies Pressure BioSciences and Artivion, analyzing factors including revenue, earnings, valuation, institutional ownership, profitability, and analyst recommendations. Artivion outperforms Pressure BioSciences on 13 of 14 compared factors, with Artivion generating $441.33 million in revenue versus $1.98 million for Pressure BioSciences. Analyst consensus favors Artivion with a $51.00 price target representing 35.53% potential upside, while Pressure BioSciences carries no analyst ratings.GlobeNewswirePressure BioSciences, Inc. to Host Business and FinancialPressure BioSciences will host a teleconference on June 20, 2024, at 4:30pm ET to update investors on business and financial topics. The call will cover FY2023 results, FY2024 outlook, relocation status, and new product releases, with a replay available afterward.GlobeNewswirePressure BioSciences, Inc. to Host Business and FinancialPressure BioSciences, Inc. will host a teleconference on June 19, 2024, at 4:30 PM ET to update investors on business and financial topics. The call will cover FY 2023 results, FY 2024 outlook, relocation status, and product expansion, including expected Q3/Q4 2024 releases of nanoemulsified products.GlobeNewswireUncle Bud's Health & Wellness Experiencing Powerful Growth One Month Following Acquisition by Pressure BioSciences, Inc.Pressure BioSciences acquired Uncle Bud's Health & Wellness on January 19, 2024, and the company reported strong early results. Amazon sales rose 60% month-over-month, DTC sales increased 16%, and new subscriptions surged 138%. The company also plans celebrity endorsements and an influencer campaign.GlobeNewswirePressure BioSciences Completes Relocation into NewPressure BioSciences consolidated its Boston-area operations into a new facility in Canton, Mass., uniting all personnel into a single site. The facility will house R&D, manufacturing, formulation services, and a demo lab, aiming to streamline production and support growth, including its acquired subsidiary Uncle Bud's Health & Wellness.PressurebiosciencesPressure BioSciences Announces Closing of Uncle Bud’s Acquisition in All-Stock Transaction, Completing UltraShear Nanoemulsions Forward Integration with World Class Marketing & SalesPressure BioSciences completed the all-stock acquisition of natural health company Uncle Bud’s, integrating its marketing capabilities and product portfolio with Pressure BioSciences' UltraShear nanoemulsions technology. The combined entity expects 2024 revenues to exceed $10 million, driven by a forecasted five-fold increase in revenue and the launch of new products utilizing enhanced CBD formulations.PressurebiosciencesPressure BioSciences Signs Definitive Agreement to Acquire Uncle Bud’s, Forward Integrating PBIO’s UltraShear Platform into Multiple MarketsPressure BioSciences has signed a definitive agreement to acquire Uncle Bud’s, combining its UltraShear technology platform with the latter's established brand and customer base. The transaction, expected to close by January 19, 2024, involves an exchange of preferred stock convertible into common shares and includes performance-based earnouts. The combined entity aims to accelerate revenue growth and expand into new consumer markets such as skincare, beverages, and pet care.GlobeNewswireNew to The Street’s Client Loyalty Shines: 9 Clients Recommit for Monthly Media Series Throughout 2024!FMW Media Work's New to The Street announced nine companies recommitted for monthly media series throughout 2024, including Reliance Global Group, Vector Space Biosciences, and Pressure BioSciences. The shows will air on major cable networks and stream on the company's website, with digital billboard ads in New York City.